About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Relationship Between "FODMAPs" and "GVHD" | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNCT04660487

Relationship Between "FODMAPs" and "GVHD"

With the stem cell transplanting increasing, patients which effected with "GVHD" were also increased. To evaluation the relationship between "FODMAPs" and "GVHD", Bone marrow transplant patients were ...

Lead sponsor: The First Affiliated Hospital of Soochow University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

xiaofei qi

CONTACT

+13812616208 [email protected]

Depei Wu

CONTACT

+13812616208 [email protected]

Sponsors

Lead Sponsor

The First Affiliated Hospital of Soochow University

The feces were collected from the patients who had been successfully transplanted after bone marrow transplantation. After 24 hours of culture in the culture medium, the degradation rate of "FODMAPs" was detected, and the relationship between the degradation rate and the occurrence time and degree of "GVHD" was observed

Age

18 - 60 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Clinical diagnosis of "AML","ALL","MDS" or "MM" Disease;
•2. Must be treated with bone marrow transplantation;
•3. The transplanted bone marrow was successfully planted

Exclusion Criteria

•1. Gastrointestinal diseases；
•2. Age\>60; or Age\<10；
•3. Probiotics or prebiotics were taken before enrollment

Related studies

RECRUITINGPhase 1

Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation

NCT06008808 · Graft Vs Host Disease, Graft-versus-host-disease, and more

RECRUITINGPhase 3

Study Comparing Reduced Versus Standard Dose Post-transplantation Cyclophosphamide in Combination With Post-engraftment Anti-thymoglobin as Graft Versus Host Disease Prophylaxis in Alternative Donor Peripheral Stem Cell Transplantation

NCT06705062 · Allogeneic Hematopoietic Cell Transplant, Graft Versus Host Disease

RECRUITINGPhase 3

A Long-term Extension Study of PCI-32765 (Ibrutinib)

NCT01804686 · Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and more

RECRUITINGPhase 2

Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma

NCT07356245 · T-cell Lymphoma, Graft Versus Host Disease, and more

Efficacy and Safety of Auto-FMT in Preventing aGVHD

NCT04745221 · Graft Versus Host Disease, Acute

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 31, 2025Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment100

Start dateDec 2020

Last updatedDec 31, 2025

Condition

Graft Versus Host Disease

Locations shown

中国

Suzhou, Jiangsu

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 31, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions